Cas 279229-14-0,3-amino-N-(4-cyano-3-trifluoromethyl-phenyl)-2-hydroxy-2-methyl-propionamide

279229-14-0

Post Buying Request

Basic information

Product Name: 3-amino-N-(4-cyano-3-trifluoromethyl-phenyl)-2-hydroxy-2-methyl-propionamide
Synonyms: 3-amino-N-(4-cyano-3-trifluoromethyl-phenyl)-2-hydroxy-2-methyl-propionamide
CAS NO:279229-14-0
Molecular Formula:
Molecular Weight: 287.241
EINECS: N/A
Product Categories: N/A
Mol File: 279229-14-0.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-amino-N-(4-cyano-3-trifluoromethyl-phenyl)-2-hydroxy-2-methyl-propionamide(CAS DataBase Reference)
NIST Chemistry Reference: 3-amino-N-(4-cyano-3-trifluoromethyl-phenyl)-2-hydroxy-2-methyl-propionamide(279229-14-0)
EPA Substance Registry System: 3-amino-N-(4-cyano-3-trifluoromethyl-phenyl)-2-hydroxy-2-methyl-propionamide(279229-14-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 279229-14-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

279229-14-0 Suppliers

Recommended suppliersmore

279229-14-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 279229-14-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,9,2,2 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 279229-14:
(8*2)+(7*7)+(6*9)+(5*2)+(4*2)+(3*9)+(2*1)+(1*4)=170
170 % 10 = 0
So 279229-14-0 is a valid CAS Registry Number.

279229-14-0Upstream product

90357-51-0 N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide

279229-14-0Downstream Products

279229-14-0Relevant articles and documents

NOVEL HETEROCYCLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)

-

Page/Page column 145, (2008/06/13)

The present invention is directed to novel heterocycle derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 279229-14-0